Here we go Again …..


Recap for the window lickers:

-HIV got whacked. EPG. Buh bye.
-CVM literally has scheduled layoffs coming.
-IMM/GI laid off ALL Syneos.
-Neuro is on the table as well, no surprise.

Thanks for attending my TED talk.
 
















































I am shocked that they ditched HIV. Symtuza has a substantial market share in my territory, has a fast start indication and is very much sample driven. They honestly need the reps even if they have no pipeline for the future. I am sure the reps are scratching their heads in bewilderment.
(from a competitor rep)
 








Don’t believe everything you reed hear, HIV not going anywhere.
I am shocked that they ditched HIV. Symtuza has a substantial market share in my territory, has a fast start indication and is very much sample driven. They honestly need the reps even if they have no pipeline for the future. I am sure the reps are scratching their heads in bewilderment.
(from a competitor rep)
 








As this will affect careers and families -spill specifics on what you know please. Or leave

And here is the window licker. Exactly how much more specific would you like that information?

-Infectious disease had their lay off.
-Immunology GI had their lay off.
-CVM is slated for this fall; idk why this is news to you. Xarelto is end of its pathetic parent life and they’ve been diminishing that division for years. So…that will happen again. Specifically institution reps and more. -And also Neurology getting layoffs.
 
























So sad such a cake
Job
It was.
I am shocked that they ditched HIV. Symtuza has a substantial market share in my territory, has a fast start indication and is very much sample driven. They honestly need the reps even if they have no pipeline for the future. I am sure the reps are scratching their heads in bewilderment.
(from a competitor rep)